For the second month in a row, the NHS has met the 28-day faster diagnosis target for cancer
Category: News
Anticancer drugs will be responsible for 90% of nearly 612,000 predicted US cancer deaths in 2024
The subtype accounts for 20% of all T-cell leukaemias, a rare form of blood cancer which produces too […]
The findings could potentially lead to new therapies and could stop the growth of cancers
Gossamer’s seralutinib is designed to treat pulmonary arterial hypertension and other indications
The chronic brain disease that causes seizures currently affects around 600,000 people living in the UK
The rare and fatal progressive neurodegenerative disease is estimated to affect 5,000 people in the UK
Neurological disorders, such as epilepsy or chronic pain, affect over three billion people worldwide
The INTerpath-001 trial is evaluating Moderna/Merck’s mRNA-4157 in combination with Merck’s Keytruda